id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-336563-hwemigk7	Bhimraj, Adarsh	Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19	2020-04-27		.txt	text/plain	8308	448	42	Given the rapidity of emerging literature, IDSA identified the need to develop living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19. Two RCTs of patients with confirmed COVID-19 with mild pneumonia (e.g., positive CT scan without oxygen requirement) or non-severe infection admitted to the hospital treated with hydroxychloroquine (HCQ) reported on mortality at 14 days, clinical progression (radiological progression on CT scan), clinical improvement, failure of virologic clearance (PCR), and adverse events (both) [11, 12] (Table 1 ). In addition, we identified four publications describing three trials of combination treatment with HCQ plus azithromycin (AZ) among hospitalized patients with COVID-19 reporting on the outcomes of mortality, failure of virologic clearance (assessed with PCR test), and adverse events (i.e., significant QT prolongation leading to treatment discontinuation) [13] [14] [15] [16] (Table 2) .	./cache/cord-336563-hwemigk7.txt	./txt/cord-336563-hwemigk7.txt